1846-26-R-RFPR-00001

The Mississippi Board of Pharmacy is seeking a contractor to provide a comprehensive Pharmacy Professionals Recovery Program through a Request for Proposals (RFP) for a contract effective from December 1, 2025, to June 30, 2029, with a potential one-year renewal option. The primary objective is to support impaired pharmacists, pharmacy students, and pharmacy technicians licensed or registered with the Board, focusing on addressing substance abuse disorder, mental health, and physical illness that may impact professional practice safety. Key deliverables include developing individualized treatment plans, conducting drug testing, monitoring participant progress, providing 24-hour interventions, maintaining a referral list of treatment providers, and submitting quarterly reports. The evaluation criteria will be comprehensive, with 40% allocated to cost (35% price to MSBOP, 5% monthly member fees), 25% to management, 25% to technical aspects, and 10% to quality improvement and governance. Proposals are due by September 12, 2025, at 2:00 p.m. CT, with an anticipated contract award on November 6, 2025.

The RFP does not explicitly mention specific set-aside designations or restrictions for disadvantaged enterprises. The current services are partially provided by the Mississippi Association of Recovering Pharmacists, suggesting potential incumbent involvement. The contractor must have a certified Medical Review Officer, an independent review committee, and capabilities for direct participant communication and educational program collaboration. The total anticipated contract amount is $1,500,000, with monthly payments to be made in arrears upon completion of services and detailed invoicing. The program historically serves between 40 to 60 individuals, and the contract will be funded directly by the Mississippi Board of Pharmacy. Contractors will be required to submit detailed invoices for services rendered, with no prepayments or initial deposits, and specific monthly rates will be outlined in the contract's Exhibit A.